RxDoctor Payments Data

Timothy James

Optometrist · Littleton, CONPI 1528064532

Payments from drug & device makers

$1,812in general payments, 2019–2025

Across 23 payments — averaging $78.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Carl Zeiss Meditec USA, Inc.$1K
  • Coopervision Inc.$219
  • ABB Con-cise Optical Group LLC$55
  • Carl Zeiss Meditec AG$39
  • Bausch & Lomb Americas Inc.$35
  • Alcon$22
  • plus $17 from 1 others

What the payments were for

  • Food & beverage$33118%
  • Gifts$563%
  • Other$1,42579%

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,812 in reported general payments places this provider in the 75th percentile of 1,025 optometrist providers in Colorado.

See all optometrist providers in Colorado

Medicare billing

Part B allowed, 2024
$53,439
Medicare patients
281
Services billed
632

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LumiganBimatoprost15$3,786
SimbrinzaBrinzolamide/Brimonidine Tart11$2,222
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol11$1,203
Latanoprost77$791
Tobramycin-DexamethasoneTobramycin/Dexamethasone11$472
Ofloxacin14$175
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha11$149
ErythromycinErythromycin Base17$137
Brimonidine Tartrate12$70

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AlconSimbrinza$22$2,22211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,025 optometrist providers in Colorado.

Other optometrist in Littleton

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →